Plexision
BiotechnologyView the employees at
Plexision-
Brianna Spishock Clinical Laboratory Scientist | Data Analyst
-
Pittsburgh, Pennsylvania, United States
-
Rising Star
Manuel Baylan Biomedical Engineer at Bayer-
Miami-Fort Lauderdale Area
-
Rising Star
Ashok Reddy Officer at Plexision-
Rising Star
Allyson Bartlett Recent Graduate from the Forensic Science Master's Program at UC Davis-
Pittsburgh, Pennsylvania, United States
-
Rising Star
Overview
Plexision develops cellular biomarkers for personalized diagnosis and drug development in solid organ transplantation, and immunological disorders. Plexision's first patented product, the PleximmuneTM assay, predicts the risk of transplant rejection. The test is based on patent-pending technology to measure antigen-specific white blood cells. Testing services for transplant recipients and drug developers are provided at Plexision’s CLIA-certified, central laboratory in Pittsburgh. Plexision currently offers cell-based testing for personalized assessment of rejection risk after solid organ transplantation The Pleximmune blood test is the first such test offered for children with liver or intestine transplantation.
-